FITFX
Price
$14.00
Change
-$0.11 (-0.78%)
Updated
Sep 20 closing price
VDVIX
Price
$12.93
Change
-$0.16 (-1.22%)
Updated
Sep 20 closing price
Ad is loading...

FITFX vs VDVIX

Header iconFITFX vs VDVIX Comparison
Open Charts FITFX vs VDVIXBanner chart's image
Fidelity Flex International Index
Price$14.00
Change-$0.11 (-0.78%)
VolumeN/A
CapitalizationN/A
Vanguard Developed Markets Index I
Price$12.93
Change-$0.16 (-1.22%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FITFX vs VDVIX Comparison Chart
Loading...
VS
FITFX vs. VDVIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FITFX is a StrongBuy and VDVIX is a Buy.

FUNDAMENTALS
Fundamentals
VDVIX has more cash in the bank: 204B vs. FITFX (2.52B). VDVIX pays higher dividends than FITFX: VDVIX (3.17) vs FITFX (2.55). FITFX was incepted earlier than VDVIX: FITFX (8 years) vs VDVIX (11 years). FITFX (3.00) and VDVIX (3.00) have comparable annual turnover. FITFX (0) and VDVIX (0) have matching initial minimum investment requirements. FITFX annual gain was more profitable for investors over the last year : 16.94 vs. VDVIX (14.53). FITFX return over 5 years is better than : 33.74 vs. VDVIX (26.85).
FITFXVDVIXFITFX / VDVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years11 years-
Gain YTD9.5967.819123%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.52B204B1%
Annual Yield % from dividends2.553.1781%
Returns for 1 year16.9414.53117%
Returns for 3 years6.080.441,390%
Returns for 5 years33.7426.85126%
Returns for 10 yearsN/A33.71-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GROY1.32N/A
N/A
Gold Royalty Corp
ROK262.74-0.46
-0.17%
Rockwell Automation
AQN5.50-0.01
-0.18%
Algonquin Power & Utilities Corp
ACST2.72-0.01
-0.37%
Acasti Pharma
ANAB36.57-0.93
-2.48%
AnaptysBio